What predicts attrition in second step medication treatments for depression?: a STAR*D Report
Diane Warden(Southwestern Medical Center), Madhukar H. Trivedi(Southwestern Medical Center), G.K. Balasubramani(University of Pittsburgh), Stephen R. Wisniewski(University of Iowa), Susan G. Kornstein(Virginia Commonwealth University), Kathy Shores‐Wilson(The University of Texas Southwestern Medical Center), Michael E. Thase(Veterans Health Administration), Sheldon Preskorn(University of Kansas), Elizabeth A. Young(North Shore University Hospital), Ira M. Lesser(The Lundquist Institute), Andrew A. Nierenberg(Harvard University), A. John Rush(The University of Texas Southwestern Medical Center)
Cited by 79
Related Papers
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
|Biological Psychiatry|2003|3.9k
A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression
|New England Journal of Medicine|2000|1.3k
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
|Controlled Clinical Trials|2004|1.1k
Frontiers of cognitive therapy
|General Hospital Psychiatry|1997|1.1k
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation
|Psychological Medicine|2004|989